# Efficacy of Rilpivirine-based Regimens as Switch Therapy From Nevirapine-based Regimens in HIV-infected Patients

> **NCT03664440** · NA · COMPLETED · sponsor: **Mahidol University** · enrollment: 106 (actual)

## Conditions studied

- Efficacy of Rilpivirine-based Regimens as Switch Therapy

## Interventions

- **DRUG:** Nevirapine
- **DRUG:** Rilpivirine

## Key facts

- **NCT ID:** NCT03664440
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-01
- **Primary completion:** 2017-10-31
- **Final completion:** 2017-10-31
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2018-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03664440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03664440, "Efficacy of Rilpivirine-based Regimens as Switch Therapy From Nevirapine-based Regimens in HIV-infected Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03664440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*